| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | INVE | Common Stock | Sale | $402,471 | -16,414 | -5.6% | $24.52 | 278,825 | 08 Nov 2021 | Direct | F1, F2, F3, F5 |
| transaction | INVE | Common Stock | Sale | $317,590 | -13,000 | -4.7% | $24.43 | 265,825 | 09 Nov 2021 | Direct | F1, F2, F4, F5 |
| Id | Content |
|---|---|
| F1 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 3, 2021. |
| F2 | Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold. |
| F3 | Represents a weighted average price. Actual sale prices ranged from $24.30 to $24.75. |
| F4 | Represents a weighted average price. Actual sale prices ranged from $23.86 to $24.74. |
| F5 | Includes an aggregate of 2,918 shares of common stock issuable pursuant to Restricted Stock Unit awards that have not vested. |